Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Michał Gniot"'
Autor:
Michał Janowski, Karolina Łuczkowska, Michał Gniot, Krzysztof Lewandowski, Krzysztof Safranow, Grzegorz Helbig, Bogusław Machaliński, Edyta Paczkowska
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 8, p 2353 (2024)
Background and Objectives: The effective treatment of chronic myeloid leukemia leads to the restoration of proper immune system function. We aimed to investigate fluctuations in circulating cytokines, angiogenic factors and complement components in p
Externí odkaz:
https://doaj.org/article/f1b28243437549ddb2160a95b20c27b5
Autor:
Marta Libura, Karolina Karabin, Paweł Tyrna, Anna Czyż, Hanna Makuch-Łasica, Bożena Jaźwiec, Monika Paluszewska, Beata Piątkowska-Jakubas, Magdalena Zawada, Michał Gniot, Joanna Trubicka, Magdalena Szymańska, Katarzyna Borg, Marta Więsik, Sylwia Czekalska, Izabela Florek, Maria Król, Małgorzata Paszkowska-Kowalewska, Lidia Gil, Katarzyna Kapelko-Słowik, Elżbieta Patkowska, Agnieszka Tomaszewska, Krzysztof Mądry, Rafał Machowicz, Tomasz Czerw, Agnieszka Piekarska, Magdalena Dutka, Anna Kopińska, Grzegorz Helbig, Tomasz Gromek, Krzysztof Lewandowski, Marta Zacharczuk, Anna Pastwińska, Tomasz Wróbel, Olga Haus, Grzegorz Basak, Jerzy Hołowiecki, Przemysław Juszczyński, Ewa Lech-Marańda, Sebastian Giebel, Wiesław Wiktor Jędrzejczak
Publikováno v:
Cancers, Vol 15, Iss 22, p 5431 (2023)
Adult acute lymphoblastic leukemia (ALL) is associated with poor outcomes. ALL is initiated by primary aberrations, but secondary genetic lesions are necessary for overt ALL. In this study, we reassessed the value of primary and secondary aberrations
Externí odkaz:
https://doaj.org/article/391cd13c435b484e84778bf4b8136270
Autor:
Krzysztof Lewandowski, Michał Gniot, Maria Lewandowska, Anna Wache, Błażej Ratajczak, Anna Czyż, Małgorzata Jarmuż-Szymczak, Mieczysław Komarnicki
Publikováno v:
Case Reports in Medicine, Vol 2016 (2016)
The coexistence of two diseases chronic myeloid leukemia (CML) and B-cell chronic lymphocytic leukemia (B-CLL) is a rare phenomenon. Both neoplastic disorders have several common epidemiological denominators (they occur more often in men over 50 year
Externí odkaz:
https://doaj.org/article/dfa939adc8b34da5b7d2f1f5d49cfe8a
Autor:
Marzena Wojtaszewska, Rafał Stępień, Alicja Woźna, Maciej Piernik, Pawel Sztromwasser, Maciej Dąbrowski, Michał Gniot, Sławomir Szymański, Maciej Socha, Piotr Kasprzak, Rafał Matkowski, Paweł Zawadzki
Publikováno v:
Molecular Diagnosis & Therapy
Background and Objective Human epidermal growth factor receptor 2 (HER2) protein overexpression is one of the most significant biomarkers for breast cancer diagnostics, treatment prediction, and prognostics. The high accessibility of HER2 inhibitors
Autor:
Krzysztof Lewandowski, Zuzanna Kanduła, Michał Gniot, Edyta Paczkowska, Paulina Maria Nawrocka, Marzena Wojtaszewska, Michał Janowski, Magdalena Mariak, Luiza Handschuh, Piotr Kozlowski
Publikováno v:
Annals of hematology. 101(12)
It has been postulated that the changes in the molecular characteristics of the malignant clone(s) and the abnormal activation of JAK-STAT signaling are responsible for myeloproliferative neoplasm progression to more advanced disease phases and the i
Autor:
Michał Janowski, Zofia Ulańczyk, Karolina Łuczkowska, Anna Sobuś, Dorota Rogińska, Ewa Pius-Sadowska, Michał Gniot, Krzysztof Kozłowski, Krzysztof Lewandowski, Grzegorz Helbig, Bogusław Machaliński, Edyta Paczkowska
Publikováno v:
OncoTargets and therapy. 15
MichaÅ Janowski,1,* Zofia UlaÅczyk,2,* Karolina Åuczkowska,2 Anna SobuÅ,2 Dorota RogiÅska,2 Ewa Pius-Sadowska,2 MichaÅ Gniot,3 Krzysztof KozÅowski,4 Krzysztof Lewandowski,3 Grzegorz Helbig,5 BogusÅaw MachaliÅski,2 Edyta Pac
Autor:
Krzysztof Lewandowski, Zuzanna Kanduła, Michał Gniot, Edyta Paczkowska, Paulina Maria Nawrocka, Marzena Wojtaszewska, Michał Janowski, Magdalena Mariak, Luiza Handschuh, Piotr Kozlowski
Background: JAK-STAT pathway activation leads to an enhanced activity of the promoter of CD274 (PDL1) coding programmed death-1 receptor ligand (PD-L1), increased PD-L1 level and the immune escape of myeloproliferative neoplasms (MPN) cells. It has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ed003b5d7df8192fd190d1ec23fe2c8
https://doi.org/10.21203/rs.3.rs-1347762/v1
https://doi.org/10.21203/rs.3.rs-1347762/v1
Autor:
Michał Gniot, Anna Przybylowicz-Chalecka, Joanna Czerwinska-Rybak, Mieczysław Komarnicki, Błażej Ratajczak, Malgorzata Jarmuz-Szymczak, Krzysztof Lewandowski
Publikováno v:
Leukemia & Lymphoma. 61:189-193
Karyotype with the presence of a cryptic rearrangement involving the BCR-ABL1 fusion gene may be found in chronic myeloid leukemia (CML) patients with apparently normal karyotype, or in cases where...
Autor:
Marek Dudziński, Justyna Gil, Iwona Pietkun, Krzysztof Giannopoulos, Joanna Niesiobedzka-Krezel, Joanna Góra-Tybor, Grażyna Bober, Ewa Wasilewska, Ewa Mędraś, Jadwiga Hołojda, Tomasz Sacha, Monika Szarejko, Olga Grzybowska-Izydorczyk, Krzysztof Myśliwiec, Joanna Wącław, Michał Gniot
Publikováno v:
American Journal of Hematology. 92:E125-E128
The efficacy and safety of imatinib generics were not studied and reported on larger cohort of patients yet. We report on efficacy and safety of imatinib generics in 726 chronic myeloid leukemia patients in chronic phase who completed one-year observ
Autor:
Vibe Skov, Mikkel H Dorff, Michał Gniot, Morten Andersen, Lene Udby, Hans Carl Hasselbalch, Lasse Kjær, Anni Aggerholm, Niels Pallisgaard, Karen Soeby, Philippe Clair
Publikováno v:
Kjaer, L, Skov, V, Andersen, M T, Aggerholm, A, Clair, P, Gniot, M, Soeby, K, Udby, L, Dorff, M H, Hasselbalch, H & Pallisgaard, N 2019, ' Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay ', European Journal of Haematology, vol. 103, no. 1, pp. 26-34 . https://doi.org/10.1111/ejh.13238
Objective: Molecular monitoring of treatment response in patients with chronic myelogenous leukemia is performed using the Europe Against Cancer (EAC) qPCR assay using the International Scale (IS). The assay amplifies both e13a2 and e14a2 BCR-ABL1 tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d892f3d73ab3e87b5c796ebc3c8eb1a1
https://pure.au.dk/portal/da/publications/variantspecific-discrepancy-when-quantitating-bcrabl1-e13a2-and-e14a2-transcripts-using-the-europe-against-cancer-qpcr-assay(ae939960-9361-465c-969e-5ce09fb5087d).html
https://pure.au.dk/portal/da/publications/variantspecific-discrepancy-when-quantitating-bcrabl1-e13a2-and-e14a2-transcripts-using-the-europe-against-cancer-qpcr-assay(ae939960-9361-465c-969e-5ce09fb5087d).html